Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, however, application to other therapies is questioned.

Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate in and Toby Maher, M.D., will deliver a keynote presentation titled "SyMMPonia: A Phase 2 Study of ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX stock a strong buy.

"We also observed an increase in symptomatic remission rates across groups in the OLE, with the 850 mg induction phase dose ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

Turmeric and its main antioxidant, curcumin, have antioxidant and anti-inflammatory effects. They may reduce pain, boost heart health, and reduce depression.

In 2016, researchers used mouse models of Parkinson's Disease (PD) to determine that short-chain fatty acid signaling modulated microglia and enhanced PD pathophysiology. It was also noted that ...

Elevated TNF alpha levels have been implicated in the pathophysiology of several chronic inflammatory ... and Listeria meningitis. In patients with ulcerative colitis, these included gastroenteritis, ...

Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% ...

3.2.2 Regulation of intestinal epithelial cell homeostasis These insights underscore the centrality of circRNA-RBP interactions in IBD pathophysiology, bridging transcriptional regulation with ...